You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The funding, part of a larger initiative by Genome Canada, will support two studies in British Columbia that will evaluate genomics in healthcare.
The assays will combine genomic and gene expression analyses to better understand driver mutations in prostate, breast, and pancreatic cancers.
The funding, provided in partnership with Agriculture and Agri-food Canada, will support research applying genomics in agriculture and aquaculture.
The money is being provided under three Genome Canada funding competitions in partnership with the Canadian federal government and other groups.
The Genome Canada program will encourage the formation of private-public partnerships to develop gene-based technologies for healthcare and agriculture.
The initiative will promote the clinical implementation of precision medicine with an initial focus on rare diseases.
Genome Canada and its partners recently funded two new initiatives with C$255 that will back precision medicine, genomics, and technology development.
The funding will support various projects and research centers that are advancing precision medicine and genomic technology development.
DivSeek was established in 2015 to support the genomic characterization of the 7 million crop accessions currently being stored at gene banks around the world.
The researchers said that better diagnostics are needed to distinguish between false preterm labor and true preterm labor to prevent unnecessary treatment.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.